Pharmacogenomics

Creating safer work environments with toxicogenomics research: worker protection, consultation and consent
pp. 209-212(4)
Author: Weinstein, Marc

Under pressure: new regulation gene discovered
pp. 213-215(3)

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity
pp. 217-225(9)
Authors: Kealey, Carmel; Chen, Zhen; Christie, Jason; Thorn, Caroline F; Whitehead, Alexander S; Price, Maureen; Samaha, Frederick F; Kimmel, Stephen E

Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV
pp. 227-235(9)
Authors: Ma, Qing; Brazeau, Daniel; Zingman, Barry S; Reichman, Richard C; Fischl, Margaret A; Gripshover, Barbara M; Venuto, Charles S; Slish, Judianne C; DiFrancesco, Robin; Forrest, Alan; Morse, Gene D

Diagnostic potential for urinary proteomics
pp. 237-255(19)
Authors: Hortin, Glen L; Sviridov, Denis

Regulation of human dihydropyrimidine dehydrogenase: implications in the pharmacogenetics of 5-FU-based chemotherapy
pp. 257-265(9)
Authors: Zhang, Xue; Diasio, Robert B

Education, ethics and knowledge deficits in clinical pharmacogenetics
pp. 267-270(4)
Author: Hedgecoe, Adam

The potential of gender-specific tumor pharmacology
pp. 271-274(4)
Author: Mader, Robert M

Awareness survey of parties involved in pharmacogenomics in Japan
pp. 275-286(12)
Authors: Tamaoki, Mieko; Gushima, Hiroshi; Tsutani, Kiichiro

dbZach toxicogenomic information management system
pp. 287-291(5)
Authors: Burgoon, Lyle D; Zacharewski, Timothy R

Comprehensive assessment of metabolic enzyme and transporter genes using the Affymetrix^® Targeted Genotyping System
pp. 293-305(13)
Authors: Dumaual, Carmen; Miao, Xin; Daly, Thomas M; Bruckner, Carsten; Njau, Reuben; Fu, Dong-Jing; Close-Kirkwood, Sandra; Bauer, Nancy; Watanabe, Nancy; Hardenbol, Paul; Hockett, Richard D